220 related articles for article (PubMed ID: 17242407)
1. Phosphorylation of thyroid hormone receptor-associated nuclear receptor corepressor holocomplex by the DNA-dependent protein kinase enhances its histone deacetylase activity.
Jeyakumar M; Liu XF; Erdjument-Bromage H; Tempst P; Bagchi MK
J Biol Chem; 2007 Mar; 282(13):9312-9322. PubMed ID: 17242407
[TBL] [Abstract][Full Text] [Related]
2. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
[TBL] [Abstract][Full Text] [Related]
3. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.
Tomita A; Buchholz DR; Shi YB
Mol Cell Biol; 2004 Apr; 24(8):3337-46. PubMed ID: 15060155
[TBL] [Abstract][Full Text] [Related]
4. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3.
Li J; Wang J; Wang J; Nawaz Z; Liu JM; Qin J; Wong J
EMBO J; 2000 Aug; 19(16):4342-50. PubMed ID: 10944117
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of thyroid hormone-dependent negative regulation by thyroid hormone receptor, nuclear receptor corepressor (NCoR), and GAGA-binding factor on the rat cD44 promoter.
Kim SW; Ho SC; Hong SJ; Kim KM; So EC; Christoffolete M; Harney JW
J Biol Chem; 2005 Apr; 280(15):14545-55. PubMed ID: 15701601
[TBL] [Abstract][Full Text] [Related]
6. The nuclear corepressors recognize distinct nuclear receptor complexes.
Cohen RN; Putney A; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
[TBL] [Abstract][Full Text] [Related]
7. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.
Jeyakumar M; Webb P; Baxter JD; Scanlan TS; Katzenellenbogen JA
Biochemistry; 2008 Jul; 47(28):7465-76. PubMed ID: 18558711
[TBL] [Abstract][Full Text] [Related]
8. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
Makowski A; Brzostek S; Cohen RN; Hollenberg AN
Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
[TBL] [Abstract][Full Text] [Related]
9. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene.
Satoh T; Monden T; Ishizuka T; Mitsuhashi T; Yamada M; Mori M
Mol Cell Endocrinol; 1999 Aug; 154(1-2):137-49. PubMed ID: 10509808
[TBL] [Abstract][Full Text] [Related]
10. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
[TBL] [Abstract][Full Text] [Related]
11. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
13. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
Cohen RN; Wondisford FE; Hollenberg AN
Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
[TBL] [Abstract][Full Text] [Related]
14. The corepressor silencing mediator for retinoid and thyroid hormone receptor facilitates cellular recovery from DNA double-strand breaks.
Yu J; Palmer C; Alenghat T; Li Y; Kao G; Lazar MA
Cancer Res; 2006 Sep; 66(18):9316-22. PubMed ID: 16982777
[TBL] [Abstract][Full Text] [Related]
15. Differences between the silencing-related properties of the extreme carboxyl-terminal regions of thyroid hormone receptors alpha 1 and beta 1.
Nishiyama K; Matsushita A; Natsume H; Mikami T; Genma R; Sasaki S; Nakamura H
J Endocrinol; 2000 Nov; 167(2):219-27. PubMed ID: 11054635
[TBL] [Abstract][Full Text] [Related]
16. TR surfaces and conformations required to bind nuclear receptor corepressor.
Marimuthu A; Feng W; Tagami T; Nguyen H; Jameson JL; Fletterick RJ; Baxter JD; West BL
Mol Endocrinol; 2002 Feb; 16(2):271-86. PubMed ID: 11818500
[TBL] [Abstract][Full Text] [Related]
17. Contribution of HDAC3 to transcriptional repression by the human papillomavirus 31 E8^E2 protein.
Dreer M; Blondzik S; Straub E; Iftner T; Stubenrauch F
J Gen Virol; 2020 Jul; 101(7):751-759. PubMed ID: 32421493
[TBL] [Abstract][Full Text] [Related]
18. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor.
Alenghat T; Yu J; Lazar MA
EMBO J; 2006 Sep; 25(17):3966-74. PubMed ID: 16917504
[TBL] [Abstract][Full Text] [Related]
19. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
Tagami T; Lutz WH; Kumar R; Jameson JL
Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
[TBL] [Abstract][Full Text] [Related]
20. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
